Latest filing published 15 Mar 2022 for Solid Biosciences Inc., €15k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Joel Solomon Zev Schneider: trading record in brief
Joel Solomon Zev Schneider (senior executive) discloses dealings in Solid Biosciences Inc. to SEC (Form 4). Between 15 November 2018 and 14 March 2022, the trades on record add up to 14 filings.
Sales make up the whole of the open-market record (10 sales, €1.4M). Besides market trades, the filings include 2 share grants and 2 option exercises. Since January 2022: no purchases and 2 sales on the market.
The record was last updated on 15 March 2022 with an open-market sale (€15k) in Solid Biosciences Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Joel Solomon Zev Schneider
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,232 shares@ US$1.10100.0% of flowCommon StockSEC:0001209191-22-018883:0
1 of 1 declaration
